David Zagzag Selected Research

David Zagzag Research Topics

Disease

60	Neoplasms (Cancer) 01/2024 - 08/2002
48	Glioma (Gliomas) 01/2020 - 05/2002
21	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 05/2002
20	Hypoxia (Hypoxemia) 01/2018 - 10/2002
11	Brain Neoplasms (Brain Tumor) 01/2024 - 05/2004
11	Astrocytoma (Pilocytic Astrocytoma) 01/2024 - 01/2003
4	Medulloblastoma 01/2021 - 01/2002
4	Rhabdoid Tumor (Rhabdoid Tumors) 05/2011 - 08/2002
3	Meningioma (Meningiomas) 12/2023 - 01/2018
3	Epilepsy (Aura) 01/2021 - 04/2014
3	Tuberous Sclerosis (Bourneville's Disease) 04/2017 - 07/2009
3	Ependymoma 01/2016 - 09/2003
3	Hemangioblastoma 05/2015 - 07/2005
3	Carcinogenesis 10/2014 - 08/2005
2	Disease Progression 01/2023 - 01/2012
2	Neurilemmoma (Schwannoma) 01/2021 - 08/2010
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021 - 08/2010
2	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 08/2010
2	COVID-19 08/2020 - 01/2020
2	Inflammation (Inflammations) 01/2018 - 10/2016
2	Drug Resistant Epilepsy 04/2017 - 07/2011
2	Neoplasm Metastasis (Metastasis) 11/2013 - 06/2002
2	Autoimmune Diseases of the Nervous System 03/2013 - 07/2011
2	Seizures (Absence Seizure) 07/2011 - 07/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2006 - 07/2005
1	Ganglioglioma 01/2023
1	Pituitary Neoplasms (Pituitary Adenoma) 10/2021
1	Lymphedema (Milroy Disease) 03/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 07/2005
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2005
7	Bevacizumab (Avastin)FDA Link 11/2014 - 10/2008
6	CytokinesIBA 01/2020 - 07/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2007
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 12/2016
5	LigandsIBA 01/2019 - 05/2004
5	Phosphotransferases (Kinase)IBA 07/2014 - 12/2004
5	alvocidib (flavopiridol)IBA 01/2011 - 05/2003
4	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2002
4	Histones (Histone)IBA 01/2018 - 05/2014
4	ParaffinIBA 01/2018 - 01/2003
4	Chemokine ReceptorsIBA 09/2017 - 07/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2016 - 12/2004
4	geldanamycinIBA 09/2007 - 08/2003
4	Protons (Proton)IBA 02/2007 - 09/2002
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 12/2013
3	AntigensIBA 01/2019 - 03/2005
3	TOR Serine-Threonine KinasesIBA 04/2017 - 12/2013
3	trans-sodium crocetinate (crocetin)IBA 04/2017 - 07/2009
3	Small Interfering RNA (siRNA)IBA 10/2014 - 06/2010
3	Dihydrotachysterol (AT 10)IBA 01/2012 - 01/2009
3	Cyclin D1IBA 01/2011 - 08/2002
3	Chemokine CXCL12IBA 08/2010 - 07/2005
3	Noscapine (Narcotine)IBA 08/2008 - 05/2006
3	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2004 - 05/2002
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2024 - 09/2003
2	Hematoxylin (Haematoxylon)IBA 01/2024 - 09/2003
2	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 03/2021 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 03/2021 - 10/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 09/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 10/2014
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2013
2	Formaldehyde (Formol)FDA Link 01/2018 - 11/2013
2	Oxygen (Dioxygen)IBA 01/2018 - 07/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2017 - 09/2012
2	CystathionineIBA 01/2017 - 10/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2016 - 08/2012
2	isocitric acid (isocitrate)IBA 12/2016 - 02/2011
2	Monoclonal AntibodiesIBA 05/2015 - 10/2008
2	Messenger RNA (mRNA)IBA 10/2014 - 10/2002
2	Neurofibromin 2 (Merlin)IBA 07/2014 - 08/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 04/2014 - 12/2013
2	Mitogen-Activated Protein KinasesIBA 12/2013 - 01/2012
2	AutoantibodiesIBA 03/2013 - 03/2012
2	AntibodiesIBA 03/2012 - 07/2011
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2012 - 07/2011
2	Temozolomide (Temodar)FDA LinkGeneric 02/2012 - 10/2008
2	plerixafor FDA Link 08/2010 - 12/2006
2	Hypoxia-Inducible Factor 1IBA 06/2010 - 12/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2010 - 08/2006
2	Angiogenesis InhibitorsIBA 01/2009 - 10/2008
2	Apoptosis Inducing FactorIBA 07/2008 - 05/2003
2	Cytochromes c (Cytochrome c)IBA 07/2008 - 05/2003
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2006 - 07/2005
2	N-acetylaspartate (N-acetyl aspartate)IBA 10/2005 - 11/2003
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2005 - 02/2004
1	Alprostadil (Muse)FDA LinkGeneric 01/2024
1	RadiopharmaceuticalsIBA 12/2023
1	gallium Ga 68 dotatateIBA 12/2023
1	lutetium Lu 177 dotatateIBA 12/2023
1	somatostatin receptor 2IBA 12/2023
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2023
1	Growth Hormone (Somatotropin)IBA 10/2021

Therapy/Procedure

30	Therapeutics 12/2023 - 01/2002
9	Radiotherapy 01/2016 - 06/2002
7	Drug Therapy (Chemotherapy) 10/2012 - 01/2003
4	Immunotherapy 11/2019 - 05/2004
3	Lasers (Laser) 01/2018 - 01/2003